Psilocybin Therapeutic Research: The Present and Future Paradigm
ACS Medicinal Chemistry Letters – March 02, 2020
Source: OpenAlex
Summary
Psilocybin, the active compound in "magic mushrooms," presents a compelling new avenue in medicine, potentially addressing mental health disorders and addiction without the overdose risks of drugs like cocaine or alcohol. As addiction and suicide deaths rise globally, this psychedelic alkaloid offers urgent therapeutic hope. Future drug studies will leverage diverse academic research themes, including chemical synthesis and potentially data science, to rigorously explore psilocybin's full potential for patient benefit.
Abstract
Psilocybin, an active component in "magic mushroom", may have the potential to meet the therapeutic needs for a number of indications without the addictiveness and overdose risk of other mind-altering drugs, such as cocaine, heroin, alcohol, methamphetamine, and so forth. The need for new therapies is urgent because addiction, overdose, and suicide deaths have risen throughout the United States and around the world. Anecdotal and contemporary pharmacological reports have provided some indication about the therapeutic use of psilocybin for the treatment of mental health disorders such as major depressive disorder and addiction disorders. In this Viewpoint, I summarize the current state of psilocybin therapeutic research and attempt to provide some insight into future directions on which the scientific community may wish to focus.